Replacement - Transaction in Own Shares
Source: RNS
Transaction in own shares - Correction
The Reckitt Benckiser Group plc announcement released on 15 March 2024 at 07.00 under RNS No 9508G has been amended.
Amendments are identified with an asterisk (*).
The full amended text is shown below.
Reckitt Benckiser Group plc (the "Company") announces today it has purchased the following number of its ordinary shares of 10 pence each ("shares") from Merrill Lynch International in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2023 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 19 December 2023, as announced on 20 December 2023. The repurchased shares will be held in treasury.
Ordinary Shares
|
Date of purchase: |
14 March 2024 |
|
Aggregate number of ordinary shares purchased: |
214,536 |
|
Highest price paid per share (pence): |
5,308.00 |
|
Lowest price paid per share (pence): |
5,236.00 |
|
Volume weighted average price paid per share (pence): |
5,265.80 |
Following settlement of the above transaction, the Company will hold 26,997,201* of its ordinary shares in treasury and have 709,537,978* ordinary shares in issue (excluding treasury shares).
Therefore, the total number of voting rights in the Company will be 709,537,978* and this figure may be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it applies in the UK, a full breakdown of the individual trades made by the Broker on behalf of the Company is detailed below:
http://www.rns-pdf.londonstockexchange.com/rns/1194H_1-2024-3-15.pdf
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
